4/19
08:42 am
crmd
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath [Yahoo! Finance]
Medium
Report
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath [Yahoo! Finance]
4/19
08:30 am
crmd
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
Medium
Report
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
4/15
08:39 am
crmd
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) [Yahoo! Finance]
High
Report
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) [Yahoo! Finance]
4/15
08:30 am
crmd
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
High
Report
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
4/11
11:41 am
crmd
Wall Street Analysts Predict a 146.21% Upside in CorMedix (CRMD): Here's What You Should Know [Yahoo! Finance]
Medium
Report
Wall Street Analysts Predict a 146.21% Upside in CorMedix (CRMD): Here's What You Should Know [Yahoo! Finance]
4/11
08:37 am
crmd
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference [Yahoo! Finance]
High
Report
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference [Yahoo! Finance]
4/11
08:30 am
crmd
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
High
Report
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
4/9
08:44 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $19.00 price target on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $19.00 price target on the stock.
4/9
08:09 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
4/8
08:49 am
crmd
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC [Yahoo! Finance]
Low
Report
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC [Yahoo! Finance]
4/8
08:30 am
crmd
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
Low
Report
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
4/2
11:32 am
crmd
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD) [Yahoo! Finance]
Low
Report
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD) [Yahoo! Finance]
3/27
08:33 am
crmd
CorMedix Inc. to Present at the Needham Annual Healthcare Conference [Yahoo! Finance]
Low
Report
CorMedix Inc. to Present at the Needham Annual Healthcare Conference [Yahoo! Finance]
3/27
08:30 am
crmd
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
Low
Report
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
3/13
08:54 am
crmd
CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/12
04:30 pm
crmd
CorMedix (CRMD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
CorMedix (CRMD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/12
07:43 am
crmd
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/12
07:30 am
crmd
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Low
Report
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/6
08:51 am
crmd
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024 [Yahoo! Finance]
Low
Report
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024 [Yahoo! Finance]
3/6
08:30 am
crmd
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
Low
Report
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
1/31
02:13 pm
crmd
CorMedix Inc. (NASDAQ: CRMD) had its price target lowered by analysts at Truist Financial Co. from $18.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its price target lowered by analysts at Truist Financial Co. from $18.00 to $14.00. They now have a "buy" rating on the stock.
1/30
08:43 am
crmd
CorMedix Inc. Announces Commercial and Reimbursement Updates [Yahoo! Finance]
Medium
Report
CorMedix Inc. Announces Commercial and Reimbursement Updates [Yahoo! Finance]
1/30
08:30 am
crmd
CorMedix Inc. Announces Commercial and Reimbursement Updates
Medium
Report
CorMedix Inc. Announces Commercial and Reimbursement Updates